CN1221418A - (7s,反)-2-(2-嘧啶基)-7-(羟甲基)八氢-2h-吡啶并[1,2-a)吡嗪的制备 - Google Patents

(7s,反)-2-(2-嘧啶基)-7-(羟甲基)八氢-2h-吡啶并[1,2-a)吡嗪的制备 Download PDF

Info

Publication number
CN1221418A
CN1221418A CN97195398A CN97195398A CN1221418A CN 1221418 A CN1221418 A CN 1221418A CN 97195398 A CN97195398 A CN 97195398A CN 97195398 A CN97195398 A CN 97195398A CN 1221418 A CN1221418 A CN 1221418A
Authority
CN
China
Prior art keywords
tartrate
solution
formula
enantiomer
tartaric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97195398A
Other languages
English (en)
Chinese (zh)
Inventor
S·G·鲁格里
P·D·哈门
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of CN1221418A publication Critical patent/CN1221418A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN97195398A 1996-07-01 1997-06-16 (7s,反)-2-(2-嘧啶基)-7-(羟甲基)八氢-2h-吡啶并[1,2-a)吡嗪的制备 Pending CN1221418A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2051196P 1996-07-01 1996-07-01
US60/020,511 1996-07-01

Publications (1)

Publication Number Publication Date
CN1221418A true CN1221418A (zh) 1999-06-30

Family

ID=21799016

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97195398A Pending CN1221418A (zh) 1996-07-01 1997-06-16 (7s,反)-2-(2-嘧啶基)-7-(羟甲基)八氢-2h-吡啶并[1,2-a)吡嗪的制备

Country Status (16)

Country Link
EP (1) EP0912569A1 (es)
JP (1) JPH11512751A (es)
KR (1) KR20000022490A (es)
CN (1) CN1221418A (es)
AR (1) AR008251A1 (es)
AU (1) AU2974497A (es)
BR (1) BR9710018A (es)
CA (1) CA2259496A1 (es)
CZ (1) CZ434998A3 (es)
ID (1) ID19779A (es)
IL (1) IL127037A0 (es)
PL (1) PL330962A1 (es)
TR (1) TR199802743T2 (es)
WO (1) WO1998000425A1 (es)
YU (1) YU61098A (es)
ZA (1) ZA975806B (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX19222A (es) * 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos
DK0569387T3 (da) * 1991-01-31 1995-07-03 Pfizer Optisk adskillelse af trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2H-pyrido/1,2-a/ pyrazin

Also Published As

Publication number Publication date
YU61098A (sh) 1999-09-27
IL127037A0 (en) 1999-09-22
CA2259496A1 (en) 1998-01-08
TR199802743T2 (xx) 1999-03-22
WO1998000425A1 (en) 1998-01-08
PL330962A1 (en) 1999-06-21
BR9710018A (pt) 1999-08-10
JPH11512751A (ja) 1999-11-02
KR20000022490A (ko) 2000-04-25
CZ434998A3 (cs) 1999-11-17
AR008251A1 (es) 1999-12-29
AU2974497A (en) 1998-01-21
ZA975806B (en) 1998-12-30
EP0912569A1 (en) 1999-05-06
ID19779A (id) 1998-07-30

Similar Documents

Publication Publication Date Title
EP0565546B1 (en) (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
JPS5921684A (ja) 3−アミノキヌクリジン誘導体、該誘導体の製法及び該誘導体を用いた治療上用の薬剤
CN1612880A (zh) 制备苯基丝氨酸及其类似物的方法
JPH10504820A (ja) N−置換されたフェノチアジン類の使用
HU178302B (en) Process for producing n-amidino-3,5-diamino-6-substituted-2-piperazine-carboxamides
WO2000062782A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
JP2609410B2 (ja) (7S,トランス)−2−(2−ピリミジニル)−7−(ヒドロキシメチル)オクタヒドロ−2H−ピリド[1,2−a]ピラジンの製造
SU841589A3 (ru) Способ получени гексагидро- - КАРбОлиНОВ или иХ СОлЕй
JP2002532494A (ja) パロキセチンの誘導体
JP2000513019A (ja) 置換されたインダゾール誘導体製造のための方法及び中間体
CN1221418A (zh) (7s,反)-2-(2-嘧啶基)-7-(羟甲基)八氢-2h-吡啶并[1,2-a)吡嗪的制备
JPH10502649A (ja) ジオキソ−チオピラノ−ピリジン−カルボン酸誘導体および薬剤としてのそれらの使用
US6670476B2 (en) Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
US6576764B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
HK1019608A (en) Preparation of (7s,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]pyrazine
JP2002540101A (ja) プロピオン酸3−アミノ−3−アリールの合成
JP2003500333A (ja) 4−[(2’,5’−ジアミノ−6’−ハロゲンピリミジン−4’−イル)アミノ]シクロペント−2−エンイルメタノールの製造方法
EP1337533B1 (en) Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine
US20060241299A1 (en) Process for making spirolactone compounds
KR100342919B1 (ko) 트랜스체 염산 트라마돌의 분리 제조방법
WO2024222826A1 (zh) 用于制备寡核苷酸类似物或其盐的中间体及其制备方法
EP1569946A1 (fr) Derives de la colchicine, leur procede de preparation et utilisation
EP1178805A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
JP2002533441A (ja) 酢酸パロキセチンおよびそのアナログの製造法
JPS633864B2 (es)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1019608

Country of ref document: HK